2. Academic Validation
  3. Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma

  • J Invest Dermatol. 2016 Jun;136(6):1302-1305. doi: 10.1016/j.jid.2015.12.047.
Charles Cassius 1,  Cécile Pages 2,  Jennifer Roux 2,  Raphael Lhote 2,  Romain Lavocat 3,  Delphine Réa 4,  Martine Bagot 2,  Samia Mourah 5,  Maxime Battistella 6,  Céleste Lebbé 7,  Nicolas Dumaz 5
Affiliations

Affiliations

  • 1 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France. Electronic address: charles.cassius@gmail.com.
  • 2 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 3 Department of Plastic Surgery, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 4 Department of Hematology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 5 INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • 6 Department of Pathology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France.
  • 7 Department of Dermatology, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (APHP), Paris, France; INSERM U976 and Univ Paris Diderot, Sorbonne Paris Cité, Paris, France.
PMID: 26854489 DOI: 10.1016/j.jid.2015.12.047
Figures
Products